Website
News25/Ratings12
Price$9.28-12.76 (-57.89%)
2026-01-202026-04-23
News · 26 weeks63+240%
2025-10-262026-04-19
Mix2490d
- SEC Filings7(29%)
- Other6(25%)
- Insider5(21%)
- Earnings3(13%)
- Leadership3(13%)
Latest news
25 items- PRWeight Watchers Schedules First Quarter 2026 Earnings Conference CallNEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company") will release its results for the first quarter 2026 ended March 31, 2026, before market open on Thursday, May 7, 2026. Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About Weight WatchersWeight Watchers is the global leader in science-backed weight management, offering an integrated support system built for the GLP-
- SECSEC Form 8-K filed by WW International Inc.8-K - WW INTERNATIONAL, INC. (0000105319) (Filer)
- PRWeight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of DirectorsNEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced that it has appointed Heather Thiltgen to the Company's Board of Directors, effective April 20, 2026. Ms. Thiltgen currently serves as the President of Presbyterian Health Plan and previously served as President & CEO of WellSense Health Plan. As Weight Watchers expands its integrated weight health platform, Ms. Thiltgen brings decades of successful healthcare leadership experience with expertise in: Expanding coverage and access to GLP-1 therapies;Navigating complex regulatory environments, including
- INSIDERSEC Form 4 filed by Cotter Debra4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
- INSIDERSEC Form 3 filed by new insider Cotter Debra3 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
- INSIDERSEC Form 3 filed by new insider Gavales Lisa A3 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
- SECSEC Form 8-K filed by WW International Inc.8-K - WW INTERNATIONAL, INC. (0000105319) (Filer)
- INSIDERSEC Form 3 filed by new insider Gove Sue3 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
- INSIDERSEC Form 3 filed by new insider Volkmann Jonathan3 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
- PRWeight Watchers Launches Eli Lilly and Company's New Oral GLP-1 Foundayo® Available Through LillyDirectNEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers"), the global leader in science-backed weight management, announced that it is now offering access to Eli Lilly and Company's newly FDA-approved oral GLP-1, Foundayo® (orforglipron) through its Med+ offering and affiliated medical groups. The addition gives members a new once-daily, injection-free option for adults with obesity or overweight with weight-related medical problems and further expands the company's growing portfolio of FDA-approved oral GLP-1 treatments, all within a clinically supported program designed to help them succeed. Through Weight Watchers Med+, clinically eligible memb
- SECAmendment: SEC Form 8-K/A filed by WW International Inc.8-K/A - WW INTERNATIONAL, INC. (0000105319) (Filer)
- PRWeight Watchers Announces Board Committee AppointmentsNEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced the following updates to the composition of its Board of Directors' standing committees following the appointments of Lisa Gavales and Sue Gove as independent directors: Audit Committee: Gene Davis (Chair), Sue Gove, Carney Hawks and Nikolaj Sjoqvist;Compensation and Benefits Committee: Carney Hawks (Chair), Gene Davis and Lisa Gavales;Nominating and Corporate Governance Committee: Nikolaj Sjoqvist (Chair), Gene Davis and Sue Gove; andStrategy and Finance Committee: Gene Davis (Chair), Lisa Gavales, Car
- SECSEC Form 8-K filed by WW International Inc.8-K - WW INTERNATIONAL, INC. (0000105319) (Filer)
- PRWeight Watchers Appoints Lisa Gavales and Sue Gove to Board of DirectorsNEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced that it has appointed accomplished executives, Lisa Gavales and Sue Gove, as independent members of the Company's Board of Directors, effective April 7, 2026. Ms. Gavales and Ms. Gove will serve as directors until the Company's 2026 annual meeting of shareholders and are expected to stand for election at the annual meeting. Following these appointments, the Board consists of six directors, all of whom are independent. Lisa Gavales and Sue Gove are highly regarded consumer brand leaders with distinct exp
- SECSEC Form 8-K filed by WW International Inc.8-K - WW INTERNATIONAL, INC. (0000105319) (Filer)
- PRWeight Watchers Announces Leadership Transition and Board UpdatesOffice of the CEO Established to Oversee Business Operations Board Forms Transition Committee and Commences CEO Search NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced leadership and governance changes, including the establishment of an Office of the CEO and the formation of a new Transition Committee of the Board of Directors ("the Board"). These actions follow Tara Comonte's departure from the Company, effective March 31, 2026. The Company's Board of Directors has initiated a comprehensive search for a permanent successor with the support of a l
- PRWeight Watchers Announces Best in Market Self-Pay Wegovy® Pricing for Med+ Members and the Launch of Preferred Subscription Pricing for Wegovy via NovoCare®NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers"), the global leader in science-backed weight health, today announced that eligible Weight Watchers Med+ members will have access to subscription pricing for Wegovy® that significantly reduces out-of-pocket costs and is a result of expanded collaboration between Weight Watchers and Novo Nordisk. The new subscription offer gives Weight Watchers Med+ members access to the lowest available self-pay price in the market for doses of Wegovy not otherwise available through limited-time offers, saving cash-pay members up to $1,200 per year. The announcement coincides with Novo Nordisk's launch of the
- SECAmendment: SEC Form SCHEDULE 13G/A filed by WW International Inc.SCHEDULE 13G/A - WW INTERNATIONAL, INC. (0000105319) (Subject)
- SECSEC Form 10-K filed by WW International Inc.10-K - WW INTERNATIONAL, INC. (0000105319) (Filer)
- SECWW International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition8-K - WW INTERNATIONAL, INC. (0000105319) (Filer)
- PRWeight Watchers Announces Fourth Quarter and Full Year 2025 Results2025 Total Revenue and Adjusted EBITDA1,2 above high end of previously provided guidance Total End of Period Subscribers of 2.8 million; End of Period Clinical Subscribers of 130 thousand, up 42% year-over-year with continued growth in first quarter 2026 Fourth Quarter Total Revenue of $163 million; Clinical Subscription Revenue of $27 million, up 32% year-over-year Fourth Quarter Net Loss of $6 million; Net Loss Margin of 3.6%; Adjusted EBITDA1 of $18 million and Adjusted EBITDA Margin1 of 11.1% Provides First Quarter 2026 End of Period Subscriber Estimates and Full Year 2026 Financial Guidance NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weigh
- PRWeight Watchers Report Finds Integrated GLP-1 Support Drives Significantly Greater Weight Loss Than Medication AloneWeight Watchers' Med+ members who regularly engaged with their GLP-1 Success Program lost up to 61% more body weight in the first month and 29% more in one year, on average, than those who took medication alone. Med+ members prescribed medication also reported, on average, over 30% more weight loss than select competitors at 12 months. NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers"), the global leader in science-backed weight health, today released a GLP-1 Results Report which finds that individuals who take GLP-1 medications and regularly engage in the Weight Watchers GLP-1 Success Program achieved significantly greater weight loss and
- PRWeight Watchers Schedules Fourth Quarter and Full Year 2025 Earnings Conference CallNEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company") will release its results for the fourth quarter and full year 2025 ended December 31, 2025 before market open on Monday, March 16, 2026. Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About Weight WatchersWeight Watchers is the global leader in science-backed weight management, offering an integrated support system b
- PRWeight Watchers Partners with PVOLVE to Deliver Clinically Validated Strength Workouts to Members in the GLP-1 EraNEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers"), the global leader in science-backed weight health, today announced a strategic partnership with PVOLVE, the clinically validated workout method, designed to support longevity through strength, mobility, and stability training. As weight health enters a new era driven by GLP-1 medications and growing awareness of the role lean muscle plays in metabolism, Weight Watchers continues to innovate its science-backed approach to deliver even stronger outcomes for members. Building and preserving muscle plays an important role in long-term health, especially for women in midlife and members using GL
- PRWeight Watchers to Participate in Upcoming Investor ConferencesNEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced that the Company will be participating in the following investor conferences in January: January 12-13, 2026: ICR Conference in Orlando, FL. The Company will host meetings with investors throughout the event.January 14, 2026: CJS Securities 26th Annual New Ideas for the New Year. The Company will be participating in a virtual fireside chat at 11:00 a.m. ET. The fireside chat will be accessible via live audio webcast on the Company's corporate website, corporate.ww.com, under Events and Presentations. A r